Evidence map›Paper›PMID 38787512›Full record

ArticleJournal of physiology and biochemistry2024

Effect of virgin olive oil as spreadable preparation on atherosclerosis compared to dairy butter in Apoe-deficient mice.

Roberto Martínez-Beamonte, Cristina Barranquero, Sonia Gascón, Juan Mariño, Carmen Arnal, Gloria Estopañán, María Jesús Rodriguez-Yoldi, Joaquín Carlos Surra, Olga Martín-Belloso, Isabel Odriozola-Serrano and 4 more

Abstract readComparative Study
In one paragraph

Article in Journal of physiology and biochemistry, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Roberto Martínez-BeamonteDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, 50013, Saragossa, Spain. romartin@unizar.es.ORCID http://orcid.org/0000-0002-8100-5596
Cristina BarranqueroDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, 50013, Saragossa, Spain.
Sonia GascónDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, 50013, Saragossa, Spain.
Juan MariñoLas Arbequinas de Rosalía, Monesma de San Juan, 22415, Huesca, Spain.
Carmen ArnalInstituto Agroalimentario de Aragón, CITA-Universidad de Zaragoza, 50013, Saragossa, Spain.
Gloria EstopañánCentro de Investigación y Tecnología Agroalimentaria de Aragón (CITA), Avda. Montañana 930, 50059, Saragossa, Spain.
María Jesús Rodriguez-YoldiInstituto Agroalimentario de Aragón, CITA-Universidad de Zaragoza, 50013, Saragossa, Spain.
Joaquín Carlos SurraInstituto Agroalimentario de Aragón, CITA-Universidad de Zaragoza, 50013, Saragossa, Spain.
Olga Martín-BellosoDepartment of Food Technology, Engineering and Science, University of Lleida, Av. Alcalde Rovira Roure, 191, 25198, Lleida, Spain.
Isabel Odriozola-SerranoDepartment of Food Technology, Engineering and Science, University of Lleida, Av. Alcalde Rovira Roure, 191, 25198, Lleida, Spain.
Israel OrmanCell Technology Division. Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), CIEMAT/CIBERER, Madrid, Spain.
Jose Carlos SegoviaCell Technology Division. Centro de Investigaciones Energéticas Medioambientales y Tecnológicas (CIEMAT) and Centro de Investigación Biomédica en Red de Enfermedades Raras (CIBERER), CIEMAT/CIBERER, Madrid, Spain.
Jesús OsadaDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, 50013, Saragossa, Spain. josada@unizar.es.
María Ángeles NavarroDepartamento de Bioquímica y Biología Molecular y Celular, Facultad de Veterinaria, Instituto de Investigación Sanitaria de Aragón, Universidad de Zaragoza, 50013, Saragossa, Spain.

Funding

CIBEROBN CB06/03/1012Fondo Social Europeo B16-23RFundación Bancaria Ibercaja Cheque tecnológicoMinisterio de Ciencia e Innovación PID2019-104915RB-I00
6 · The paper itself

Abstract

Olive oil is the main source of lipid energy in the Mediterranean diet and there is strong evidence of its health benefits. The effect of extra virgin olive oil (EVOO) in the form of a preparation of spreadable virgin olive oil (S-VO) on the progression of atheroma plaques was investigated in Apoe-deficient mice, a model of accelerated atherosclerosis.

methodsTwo isocaloric Western purified diets containing 20% fat, either as S-VO or as dairy butter, were used to feed 28 males and 16 females of two-month-old Apoe-deficient mice for 12 weeks. S-VO was prepared by blending more than 75% virgin olive oil with other vegetal natural fat to obtain a solid fat. Plasma total cholesterol, triglycerides and HDL cholesterol were measured. Hepatic lipid droplets were analyzed. Areas of atherosclerotic aortic lesions were quantified in cross-sectional images of the proximal aorta and en face analysis of the whole aorta.

resultsTotal plasma cholesterol was increased in mice on the butter-supplemented diet in both female and male mice compared to S-VO, and the ratio of TC/HDL-cholesterol was significantly lower in S-VO than in the butter diet, although only in males, and no differences in plasma triglycerides were observed. No significant differences in hepatic lipid droplets were observed between diets in either sex. Aortic lesion areas were significantly higher in mice consuming the butter versus the S-VO diet in both sexes.

conclusionExtra virgin olive oil prepared in spreadable form maintained the delay in atheroma plaque progression compared to butter.

Indexed as

AtherosclerosisButterOlive OilAnimalsAortaApolipoproteins ECholesterolDisease Models, AnimalFemaleLiverMaleMiceMice, Inbred C57BLMice, Knockout, ApoEPlaque, AtheroscleroticTriglyceridesApolipoproteins EButterCholesterolOlive OilTriglyceridesApolipoprotein E deficient miceCoronary artery disease (CAD)EVOOPhenols

Identifiers

PMID38787512
PMCPMC11502577

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.